Pharma/Biotech industrien I Norden arbejder tæt sammen med health care providers, regeringer, og insitutioner som forsøger at reducere udgifter og effektivisere sundshedssektoren, I takt med at byrden af kroniske sygdomme vokser i i-landene, og udfordringer med smitsomme sygdomme og fattigdom fortsat har fatale konsekvenser for befolkningerne i u-landene. Hvordan can teknologi og innovation udnyttes til at forbedre resultaterne af vores anstrengelser inden for sundhedssektoren? Dette spørgsmål er centralt i en tid hvor de medicinske fremskridt er hastige, men hvor sundhedssektoren kæmper med at finde økonomisk råderum til at implementere de mange nye og ofte dyre behandlingsformer. Samtidigt skaber dette udfordringer med at håndtere kundernes forventning om at være berettiget til netop disse behandlinger.


Pharma/Biotech industrien står lige nu overfor en virkelighed som sætter høje krav til deres ledere. Roller og strategier bliver lige nu redefineret og behovet for at ansætte ekseptionelle ledere og specialister har aldrig været mere tydeligt. Hos Albright identificerer og vurderer vi højtperformende og motiverede  talenter fra Pharma/Biotech industren, sundhedsinsitutioner og det akademiske miljø, som er motiverede for at bidrage til at fremme health and safety.



Medtech/IVD companies involved in the design, development, manufacturing and distribution of class I, II and III products are experiencing fierce pressure from the increased professionalization of public tender professionals and tender requirements etc.


The Medtech/IVD industry in the Nordic region is working closely together with health care providers, governments, and institutions seeking to reduce cost and improve efficiencies in health care.


At Albright we maintain a comprehensive network and strong industry insights in the Medtech/IVD sector enabling us to recruit and assess highly skilled leaders, managers and specialists.



Good health can be considered one of the most fundamental resources for social and economic prosperity. In light of this health care institutions across the globe are facing tremendous challenges, and an imbalance between the demand and supply of resources is the order of the day. Rising costs and aging populations are merely two of many factors putting further strain on the health care systems. The question is: will there be shortages of health care workers to cope with demand? What’s the cost-benefit analysis of keeping aging people with deteriorating quality of life alive? And who gets to decide?


At Albright our health care practice is divided into the following sectors:


  • Public Health Care Services

  • Private Health Care Services

  • Health Care informatics

  • Health Insurance

  • Academia



European consumers are becoming increasingly health conscious, and are therefore paying closer attention to the nutritional profile of foods – including ingredient composition. This puts additional pressure on regional food and beverage manufacturers to respond by reducing or cutting out fat, salt and sugar as well as preservatives, additives and colorings.


In the feed segment, feed availability, new feed ingredients, and new feeding practices have played important roles in the concentration of food animal production operations, in particular, the now highly concentrated production of pigs and chickens. The intensification of livestock production has in turn had a significant impact on patterns of feed use, including increased demand for concentrates.

The Food & Ingredient sectors are currently facing game-changing leadership requirements with innovation, safety and speed being the main drivers. Roles and strategies are being redefined and the need to recruit exceptional leaders and specialists has never been more outspoken. At Albright, we identify and assess high performing talent from within and from outside the industry that are motivated to conduct research, business and services, and encourage a scientific dialogue leading to improved safety, innovation and efficiency.



Contract Research Organizations and Contract Manufacturing Organizations are playing an increasingly pivotal role in servicing the life sciences industry. Pharma, biotech and medtech companies in particular are making increased use of the contracted services offered by CRO/CMO’s, as they are now employing scalable business models due to increasing cost pressures and a desire to focus on their core competencies.


In parallel with pharma/biotech/medtech industries facing game-changing challenges, CRO/CMO’s must rise to the challenge and offer highly competent leaders and specialists in a future offering a shortage of talent. At Albright, we identify and assess high performing talent from the CRO/CMO and life science industry as a whole that are motivated to conduct research, business and health care services, and encourage a scientific dialogue leading to improved health and safety.



Being a cyclical business, the chemical industry is highly sensitive to changes in the global economy. Volatilities in the economy and growth being driven by Asia, will pose ongoing challenges for leaders in the European chemicals industry.


As the chemical industry in Europe will remain under pressure from the Asian markets, investments in technology development and value-adding products and services will be on the agenda. This will require access to talented and lateral thinking leaders and specialists, and the need to recruit exceptional talent will be crucial for further growth. At Albright, we identify and assess high performing talent for the chemicals industry that are motivated to conduct research and business in the pursuit of sustainable competitive advantages.



Henrik Brabrand, Managing Partner

E: hb@albright.dk


Kristian H. Larsen, Consultant

E: khl@albright.dk

NN, Partner (to be disclosed)

E: info@albright.dk

Margot Brabrand, Executive Advisor

E: mb@albright.dk


Sebastian Brabrand, EA & Lead



Sarah Carlsen, Research Associate

Emilie Glahder, Research Associate